Age
Item
1. subject must be at least 20 years of age.
boolean
C0001779 (UMLS CUI [1])
Antiplatelet therapy Dual | Antiplatelet therapy Triple | Drug-eluting stent placement Coronary Artery Disease
Item
2. subject who received dual or triple antiplatelet therapy for 1 year (± 6 months) after drug-eluting stent implantation for coronary artery disease
boolean
C1096021 (UMLS CUI [1,1])
C0205173 (UMLS CUI [1,2])
C1096021 (UMLS CUI [2,1])
C0205174 (UMLS CUI [2,2])
C4286029 (UMLS CUI [3,1])
C1956346 (UMLS CUI [3,2])
Event Clinical Absent
Item
3. subject without clinical events during 1 year (± 6 months)
boolean
C0441471 (UMLS CUI [1,1])
C0205210 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Antiplatelet therapy | Aspirin | clopidogrel
Item
4. subject who is confirmed to receive antiplatelet monotherapy (aspirin or clopidogrel)
boolean
C1096021 (UMLS CUI [1])
C0004057 (UMLS CUI [2])
C0070166 (UMLS CUI [3])
Comprehension Study Protocol | Informed Consent | Informed Consent Patient Representative
Item
5. subject is able to verbally confirm understandings of risks, benefits and treatment and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
boolean
C0162340 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2])
C0021430 (UMLS CUI [3,1])
C0030701 (UMLS CUI [3,2])
Childbearing Potential Contraceptive methods
Item
6. subject is fertile woman and able to verbally confirm using effective methods of contraception
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Aspirin allergy | Medical contraindication Aspirin | Hypersensitivity Clopidogrel | Medical contraindication Clopidogrel
Item
1. the patient has a known hypersensitivity or contraindication to aspirin or clopidogrel.
boolean
C0004058 (UMLS CUI [1])
C1301624 (UMLS CUI [2,1])
C0004057 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0070166 (UMLS CUI [3,2])
C1301624 (UMLS CUI [4,1])
C0070166 (UMLS CUI [4,2])
Antiplatelet Agents Discontinue Unable
Item
2. subject who cannot interrupt to receive antiplatelet drug.
boolean
C0085826 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
Bleeding tendency | Blood Coagulation Disorders | Requirement Discontinuation Antiplatelet Agents
Item
3. history of bleeding diathesis or known coagulopathy requiring interruption of antiplatelet drugs.
boolean
C1458140 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
C1514873 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
C0085826 (UMLS CUI [3,3])
Intervention elective Planned | Elective Surgical Procedure Planned | Requirement Discontinuation Long-term Antiplatelet Agents
Item
4. an elective intervention or surgical procedure is planned that would necessitate long-term interruption of antiplatelet drugs during the study.
boolean
C0184661 (UMLS CUI [1,1])
C0439608 (UMLS CUI [1,2])
C1301732 (UMLS CUI [1,3])
C0206058 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C1514873 (UMLS CUI [3,1])
C1444662 (UMLS CUI [3,2])
C0443252 (UMLS CUI [3,3])
C0085826 (UMLS CUI [3,4])
Liver Dysfunction | Kidney Failure
Item
5. liver function abnormality or renal failure
boolean
C0086565 (UMLS CUI [1])
C0035078 (UMLS CUI [2])
Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
ast, alt > 3 x unl
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
Creatinine measurement, serum
Item
creatinine > 2.0 mg/dl
boolean
C0201976 (UMLS CUI [1])
Comorbidity | Exception Heart Diseases | Life Expectancy
Item
6. non-cardiac co-morbid conditions are present with life expectancy < 2 years.
boolean
C0009488 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0018799 (UMLS CUI [2,2])
C0023671 (UMLS CUI [3])
Pregnancy | Breast Feeding
Item
7. subject who is pregnant, breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Study Subject Participation Status Inappropriate
Item
8. subject who is not suitable to enroll the study decided by investigator
boolean
C2348568 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])